2000;40:617–47., , . 14-3-3 proteins: structure, function, and regulation. Annual Review of Pharmacology and Toxicology
2004;14:1436–50., , , et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Current Biology
Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. Journal of Biological Chemistry 2004;279:32 046–54., , .
2004;379:395–408., , , et al. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochemical Journal
2005;57:623–9.. 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life
1993;194:144–9., , , et al. Demonstration of the phosphorylation-dependent interaction of tryptophan hydroxylase with the 14-3-3 protein. Biochemical and Biophysical Research Communications
1995;15:3390–7., , , . 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner. Molecular and Cellular Biology
1996;84:889–97., , , . Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell
1997;91:961–71., , , et al. The structural basis for 14–3–3: phosphopeptide binding specificity. Cell
1999;4:153–66., , , et al. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Molecular Cell
2010:69–78., , , et al. Bioinformatic and experimental survey of 14–3–3-binding sites. Biochemical Journal;
C-terminal recognition by 14-3-3 proteins for surface expression of membrane receptors. Journal of Biological Chemistry 2005;280:36 263–72., , , et al.
Molecular evolution of the 14-3-3 protein family. Journal of Molecular Evolution 1996;43:384–98., .
2001;127:142–9., , , . Data mining the Arabidopsis genome reveals fifteen 14-3-3 genes: expression is demonstrated for two out of five novel genes. Plant Physiology
14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. Journal of Biological Chemistry 1996;271:20 029–34., .
2000;19:1257–65., , , et al. Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. Oncogene
2004;3:672–7., , . 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle
The functional interaction of 14-3-3 proteins with the ERK1/2 scaffold KSR1 occurs in an isoform-specific manner. Journal of Biological Chemistry 2008;283:17 450–62., , , et al.
2003;3:931–43.. The 14-3-3 cancer connection. Nature Reviews Cancer
2002;50:993–1010.. Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation: chromosome location of mammalian isoforms and variants. Plant Molecular Biology
A structural basis for 14–3–3sigma functional specificity. Journal of Biological Chemistry 2005;280:18 891–8., , , .
2003;300:679–85., , . Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochemical and Biophysical Research Communications
2005;4:785–95., , , , . Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Molecular Cell Proteomics
2006;16:173–82., , . Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14–3–3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Seminars in Cancer Biology
Evolution of the 14-3-3 protein family: does the large number of isoforms in multicellular organisms reflect functional specificity?Journal of Molecular Evolution 2000;51:446–58., , , , .
2006;103:17 237–42., , , et al. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proceedings of the National Academy of Sciences USA
1995;376:188–91., , , et al. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature
1995;376:191–4., , , et al. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature
1995;14:4839–48., . Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO Journal
2000;345 Pt 2:297–306., , , , . 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochemical Journal
Identification of the major phosphorylation sites of the Raf-1 kinase. Journal of Biological Chemistry 1993;268:17 309–16., , , .
1996;87:619–28., , , , . Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell
1999;96:857–68., , , et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell
2002;513:53–7.. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Letters
14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF. Journal of Biological Chemistry 1995;270:5706–9., , , , .
14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. Journal of Biological Chemistry 1997;272:28 882–8., , , et al.
A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. Journal of Biological Chemistry 1998;273:21 834–45., , , , .
2003;23:5376–87., , , et al. Proteomic identification of 14–3–3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Molecular and Cellular Biology
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. Journal of Cell Biology 2005;170:295–304., , , .
2004;23:1889–99., , , et al. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO Journal
The Giardia duodenalis 14-3-3 protein is post-translationally modified by phosphorylation and polyglycylation of the C-terminal tail. Journal of Biological Chemistry 2006;281:5137–48., , , .
2009;325:834–40., , , et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science
1998;18:3947–55., , , et al. 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Molecular and Cellular Biology
1998;394:88–92., , . A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature
2001;105:257–67., , , , . Crystal structure of the 14–3–3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell
Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. Journal of Biological Chemistry 2003;278:29 819–23., .
1997;11:1858–67., , , . Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Molecular Endocrinology
2000;64:149–59., , , et al. Identification of a 14-3-3 protein from Lentinus edodes that interacts with CAP (adenylyl cyclase-associated protein), and conservation of this interaction in fission yeast. Bioscience, Biotechnology and Biochemistry
BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. Journal of Biological Chemistry 2000;275:25 865–9., , , .
2000;349:547–57., , . Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochemical Journal
2000;6:41–51., , , et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Molecular Cell
Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14–3–3-dependent and 14–3–3-independent pathways. Journal of Biological Chemistry 2001;276:13 402–10., , , et al.
2000;12:703–9., . 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cellular Signaling
14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. Journal of Cell Biology 2002;156:817–28., , , et al.
2001;354:605–12., , , , . Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochemical Journal
2001;21:6312–21., , . Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Molecular and Cellular Biology
1999;13:1067–72., . Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes and Development
2001;20:1839–51., , , . Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene
Promotion of importin alpha-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14–3–3. Journal of Cell Biology 2005;169:415–24., , , et al.
2006;25:1196–206., , , . Regulation of MDMX nuclear import and degradation by Chk2 and 14–3–3. EMBO Journal
2008;22:1804–15., , , et al. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes and Development
2002;111:577–88., , , . Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell
2006;16:370–5., , , . 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends in Cell Biology
2001;20:4393–401., . Cdc25B activity is regulated by 14–3–3. Oncogene
1998;9:345–54., , . 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Molecular Biology of the Cell
1997;277:1501–5., , , et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science
2001;12:581–9., , . 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth and Differentiation
2010;30:1508–27., , , et al. 14–3–3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Molecular and Cellular Biology
2010;29:305–9., , , et al. 14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1. Molecules and Cells
2008;36:5983–91., , , , . 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Research
1998;19:175–8., , , . ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genetics
2010;38:893–906., , , . Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms. Nucleic Acids Research
2003;23:7096–107., , , , . 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Molecular and Cellular Biology
2007;26:7355–62., , , et al. Roles for negative cell regulator 14–3–3sigma in control of MDM2 activities. Oncogene
2009;19:16–23.. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends in Cell Biology
2006;16:203–13., , , . 14-3-3 proteins as potential oncogenes. Seminars in Cancer Biology
14-3-3 Proteins–a focus on cancer and human disease. Journal of Molecular and Cellular Cardiology 2004;37:633–42., .
1999;401:616–20., , , , . 14–3–3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature
2007;446:329–32., , , et al. 14–3–3sigma controls mitotic translation to facilitate cytokinesis. Nature
1999;1:E73–9.. Four-dimensional control of the cell cycle. Nature Cell Biology
2007;7:495–507., , . CDC25 phosphatases in cancer cells: key players? Good targets? Nature Reviews Cancer
2003;4:671–7., . Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports
Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. Journal of Cell Biology 1999;146:573–84., , , , .
Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. Journal of Cell Science 1996;109:1081–93., , , et al.
A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea. Journal of Cell Biology 1997;138:1105–16., , , .
2002;21:4875–84., , , et al. Dual mode of degradation of Cdc25 A phosphatase. EMBO Journal
2000;1:71–9., , , , . Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Reports
2009;106:4701–6., , , , . Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletion. Proceedings of the National Academy of Sciences USA
2002;3:341–8., , . Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Reports
2007;128:1119–32., , , et al. Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell
1993;12:53–63., , , , . Phosphorylation and activation of human cdc25-C by cdc2–cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO Journal
1993;4:1337–50., . Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Molecular Biology of the Cell
2003;115:83–95., , , et al. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell
2009;21:245–55., . Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Current Opinion in Cell Biology
2003;23:7488–97., , . Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Molecular and Cellular Biology
2000;19:2179–85., , , et al. Regulation of CDC25B phosphatases subcellular localization. Oncogene
Purification of a serine kinase that associates with and phosphorylates human Cdc25C on serine 216. Journal of Biological Chemistry 1994;269:30 461–9., , .
1999;18:2174–83., , , . Maintenance of G2 arrest in the Xenopus oocyte: a role for 14–3–3-mediated inhibition of Cdc25 nuclear import. EMBO Journal
1998;9:197–208., , , et al. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth and Differentiation
1999;18:6029–36., , , et al. The physical association and phosphorylation of Cdc25C protein phosphatase by Prk. Oncogene
2001;11:78–82.. DNA damage: Chk1 and Cdc25, more than meets the eye. Current Opinion in Genetic Development
2000;408:433–9., . The DNA damage response: putting checkpoints in perspective. Nature
1998;10:240–7.. Cellular responses to DNA damage. Current Opinion in Cell Biology
1998;395:507–10., , , et al. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature
2005;17:37–48., , , et al. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Molecular Cell
2007;11:175–89., , , . p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell
2006;8:37–45., , , et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nature Cell Biology
2001;12:551–63., , . Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Molecular Biology of the Cell
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. Journal of Biological Chemistry 2000;275:23 106–12., , , .
2005;434:864–70., , , et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature
2003;22:5734–45., , , et al. PP1 control of M phase entry exerted through 14–3–3-regulated Cdc25 dephosphorylation. EMBO Journal
2006;127:759–73., , , et al. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell
2006;23:307–18., , , . Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Molecular Cell
2006;16:1950–5., , , et al. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Current Biology
2006;23:319–29., , Guardavaccaro D, et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Molecular Cell
2010;8:e1000287., , , et al. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biology
2006;16:214–24., . Epigenetic silencing of 14–3–3sigma in cancer. Seminars in Cancer Biology
CDK11(p58) is required for the maintenance of sister chromatid cohesion. Journal of Cell Science 2007;120:2424–34., , , .
2006;7:418–24., , , et al. The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Reports
2008;10:891–901., , , et al. The regulated assembly of a PKCepsilon complex controls the completion of cytokinesis. Nature Cell Biology
2000;5:597–605., , , et al. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Molecular Cell
2009;8:9., . Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Molecular Cancer
1994;371:612–14., , , et al. Activation of Raf-1 by 14-3-3 proteins. Nature
1994;265:1713–16., , , McCormick F, Ruggieri R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science
1994;266:126–9., , , et al. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science
2004;5:875–85., , . The RAF proteins take centre stage. Nature Reviews Molecular and Cellular Biology
2005;20:963–9., , , , . Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Molecular Cell
2006;26:2262–72., , , . Regulation and role of Raf-1/B-Raf heterodimerization. Molecular and Cellular Biology
2008;31:862–72., , , et al. CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. Molecular Cell
2004;116:855–67., , , et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell
, , , et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell;140:209–21.
Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. Journal of Leukocyte Biology 2003;73:689–701., .
2006;7:1., , , et al. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biology
2005;7:278–85., , , , . JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nature Cell Biology
Journal of Biological Markers 2008;23:231–7., , , et al. Clinical significance of 14-3-3 zeta in human esophageal cancer. International
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. Journal of Proteome Research 2006;5:1143–54., , , et al.
2008;105:162–7., , , et al. Down-regulation of 14–3–3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proceedings of the National Academy of Sciences USA
1997;57:4111–17., , , et al. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Research
2000;97:6049–54., , , et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proceedings of the National Academy of Sciences USA
2000;19:5298–302., , , et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene
2000;60:4353–7., , , et al. Inactivation of the 14-3-3 sigma gene is associated with 5’ CpG island hypermethylation in human cancers. Cancer Research
2001;20:3348–53., , , et al. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene
2001;61:76–80., , , et al. Proteomic analysis reveals that 14–3–3sigma is down-regulated in human breast cancer cells. Cancer Research
Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis. Journal of Proteome Research 2009;8:4050–61.., , , et al.
2006;6:3352–68., , , et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics
2008;27:1315–19., , , . Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene
2009;16:195–207., , , et al. 14–3–3zeta Cooperates with ERBB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell
2008;68:1760–7., , , et al. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Research
Proteomics of breast carcinoma. Journal of Chromatography B Analytical Technology Biomedical Life Science 2005;815:215–25., , , .
Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. Journal of Proteome Research 2004;3:604–12., , et al.
2004;14:491–9., , , , . The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncology Research
Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. International Journal of Cancer 2005;113:359–63., , , .
1994;5:123–30., , , et al. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4. Human Antibodies and Hybridomas
2005;42:97–108., , , , . Identification of differentially expressed genes in oral squamous cell carcinoma. Molecular Carcinogenesis
Gene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly involved in stroma invasion as shown by small interfering RNA-mediated gene silencing. Journal of Virology 2004;78:7478–89., , , , .
1997;1:3–11., , , et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Molecular Cell
BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. Journal of Biological Chemistry 2001;276:25 647–50., , , , .
2005;24:264–9., , , et al. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA and Cell Biology
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. American Journal of Pathology 2002;160:787–94., , , et al.
2002;62:2072–6., , , et al. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Research
2002;21:1876–81., , , et al. Coincident inactivation of 14–3–3sigma and p16INK4a is an early event in vulval squamous neoplasia. Oncogene
2004;316:1156–62., , , et al. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochemical and Biophysical Research Communications
Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma. British Journal of Cancer 2004;91:1131–8., , , et al.
2007;18:817–24., , , et al. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Oncology Report
High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder. International Journal of Molecular Medicine 2007;20:557–63., .
2007;27:214–27., , , et al. IKKalpha shields 14–3–3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Molecular Cell
2002;417:871–5., , , et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature
1999;401:616–20., , , , . 14–3–3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature
Downregulation of 14–3–3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. Journal of Cell Biology 2000;149:1117–30., , , et al.
2005;437:1043–7., , , et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature
2005;437:1038–42., . Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature
2000;100:57–70., . The hallmarks of cancer. Cell
2009;136:823–37., , . Principles of cancer therapy: oncogene and non-oncogene addiction. Cell
14–3–3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. Journal of Biological Chemistry 2009;284:22 379–89., , , et al.
2004;25:1575–85., , , et al. Enhanced expression of 14–3–3 sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis
2008;14:7614–23., . 14–3–3sigma Modulates pancreatic cancer cell survival and invasiveness. Clinical Cancer Research
, , , et al. 14–3–3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Molecular and Cell Biology; 30:1508–27.
1999;38:12 499–504., , , et al. Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry
14-3-3 proteins mediate an essential anti-apoptotic signal. Journal of Biological Chemistry 2001;276:45 193–200., .
2004;22:993–1000., , , , . Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint function. Nature Biotechnology